Biotech Biogen surges on Alzeimers drug approval
MELBOURNE: A biotech has jumped on NASDAQ following approval of a Biogen Inc. Alzheimer’s drug.
MELBOURNE: A biotech has jumped on NASDAQ following approval of a Biogen Inc. Alzheimer’s drug.
FEATURED
Cost-of-living crisis means we’re socialising less than ever
Mums push for paid grandparent childcare in subsidy shake-up
Council Multi generational affordable housing scheme wins award
Best social housing community design for Global Awards shortlisted
Older workers on age pension hit with sky-high tax rates
Best affordable housing design for Global Awards shortlisted
INNOVATION
